BioCorRx (BICX) Enterprise Value (2010 - 2026)

BioCorRx has reported Enterprise Value for 17 years, with the latest figure at -$385170.0 in Q1 2026.

• Quarterly Enterprise Value fell 43.02% year-over-year to -$385170.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$385170.0 (down 43.02% YoY) and the FY2025 annual result came in at -$442789.0, down 37.15% from the prior year.
• Enterprise Value rose to -$385170.0 in Q1 2026 per BICX's latest filing, from -$442789.0 in the prior quarter.
• Over five years, Enterprise Value peaked at $432656.0 in Q3 2025 and troughed at -$500899.0 in Q2 2025.
• A 5-year average of -$242428.4 and a median of -$269311.0 in 2025 frame the typical range for Enterprise Value.
• The widest YoY moves for Enterprise Value: up 351.71% in 2025, down 224.13% in 2025.
• Over 5 years, Enterprise Value stood at -$193872.0 in 2022, then retreated by 0.09% to -$194056.0 in 2023, then plunged by 66.37% to -$322845.0 in 2024, then tumbled by 37.15% to -$442789.0 in 2025, then grew by 13.01% to -$385170.0 in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$385170.0, -$442789.0, and $432656.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.